跳至主要内容
临床试验/NCT07619872
NCT07619872招募中不适用

KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance

Edwards Lifesciences1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2026年6月25日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250
试验地点
1

研究概览

简要总结

KONECTION is a prospective, observational, single-arm, multicenter study designed to collect real-world clinical outcomes in up to 250 participants who will receive the KONECT RESILIA aortic valved conduit, Model 11060A.

详细描述

Subjects in the KONECTION study will be enrolled at up to 20 sites in Europe and Canada. The population will be participants requiring replacement of their diseased native or prosthetic aortic valve, and the associated repair or replacement of a damaged or diseased ascending aorta.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older at the time of informed consent
  • Have a diseased native or prosthetic aortic valve and a damaged or diseased ascending aorta that requires aortic valved conduit replacement surgery with the KONECT RESILIA AVC
  • Provide written informed consent
  • Willing to follow protocol requirements

排除标准

  • Active endocarditis or endocarditis within 3 months prior to the study index procedure
  • Emergency procedure
  • Stage 4 renal disease (estimated glomerular filtration rate [eGFR] <30 excluded) or requiring dialysis
  • Less than 2-year life expectancy due to non-cardiovascular life-threatening disease in the opinion of the study investigator
  • High predicted risk of mortality prior to the procedure: Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) ≥8%

研究组 & 干预措施

Edwards KONECT RESILIA AVC

Subjects who were treated with the Edwards KONECT RESILIA AVC

干预措施: Edwards KONECT RESILIA AVC (Device)

研究者

发起方
Edwards Lifesciences
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验